Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis

In contrast to patients with viral hepatitis, patients with nonalcoholic fatty liver disease (NAFLD) can progress to hepatocellular carcinoma during the initial stages of liver fibrosis. Development and implementation of noninvasive methods for diagnosis and progression prediction are important for...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatol Commun
Auteurs principaux: Kamada, Yoshihiro, Ono, Masafumi, Hyogo, Hideyuki, Fujii, Hideki, Sumida, Yoshio, Yamada, Makoto, Mori, Kojiroh, Tanaka, Saiyu, Maekawa, Tomohiro, Ebisutani, Yusuke, Yamamoto, Akiko, Takamatsu, Shinji, Yoneda, Masashi, Kawada, Norifumi, Chayama, Kazuaki, Saibara, Toshiji, Takehara, Tetsuo, Miyoshi, Eiji
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678915/
https://ncbi.nlm.nih.gov/pubmed/29404494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1080
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires